Oncopeptides AB (publ)
ONPPF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | – | -$83 | -$61 | -$73 |
| Dep. & Amort. | – | $0 | $0 | $0 |
| Deferred Tax | – | $0 | $0 | $0 |
| Stock-Based Comp. | – | $0 | $0 | $0 |
| Change in WC | – | -$7 | -$67 | $78 |
| Other Non-Cash | – | $19 | -$3 | $4 |
| Operating Cash Flow | – | -$71 | -$130 | $9 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | – | $0 | $0 | $0 |
| Net Acquisitions | – | $0 | $0 | $0 |
| Inv. Purchases | – | $0 | $0 | $0 |
| Inv. Sales/Matur. | – | $0 | $0 | $0 |
| Other Inv. Act. | – | $0 | $0 | $0 |
| Investing Cash Flow | – | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | – | $0 | $0 | $0 |
| Stock Issued | – | $0 | $0 | $0 |
| Stock Repurch. | – | $0 | $0 | $0 |
| Dividends Paid | – | $0 | $0 | $0 |
| Other Fin. Act. | – | -$2 | -$2 | $270 |
| Financing Cash Flow | – | -$2 | -$2 | $270 |
| Forex Effect | – | $2 | -$1 | -$0 |
| Net Chg. in Cash | – | -$71 | -$133 | $278 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | – | $250 | $383 | $105 |
| End Cash | – | $179 | $250 | $383 |
| Free Cash Flow | – | -$71 | -$130 | $9 |